• 2227 Citations
  • 22 Scopus h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2009 2019

Filter
Editorial
2018

Is durvalumab the solution for unresectable stage III non-small cell lung cancer?

Duma, N., Mansfield, A. & Chen, R., Feb 1 2018, In : Translational Cancer Research. 7, p. S89-S93

Research output: Contribution to journalEditorial

Non-Small Cell Lung Carcinoma
Glass
Adenocarcinoma of lung
2017
4 Citations (Scopus)

Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?

Mansfield, A., Mar 1 2017, In : Lung Cancer. 105, p. 49-51 3 p.

Research output: Contribution to journalEditorial

Malignant Mesothelioma
3 Citations (Scopus)

Pulmonary sarcomatoid carcinoma-a new hope

Boland, J. M., Mansfield, A. & Roden, A., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1417-1418 2 p.

Research output: Contribution to journalEditorial

Lung Neoplasms
Carcinoma
Lung

Towards a Molecular Classification of Pulmonary Sarcomatoid Carcinomas

Mansfield, A., Roden, A. & Boland, J. M., Jun 1 2017, In : Journal of Thoracic Oncology. 12, 6, p. 910-912 3 p.

Research output: Contribution to journalEditorial

Carcinoma
Lung
2014
9 Citations (Scopus)

Reflections on immune checkpoint inhibition in non-small cell lung cancer

Leventakos, K. & Mansfield, A., 2014, In : Translational Lung Cancer Research. 3, 6, p. 411-413 3 p.

Research output: Contribution to journalEditorial

Non-Small Cell Lung Carcinoma